Humira Alternatives in District of Columbia
Compare generic and therapeutic alternatives to Humira (adalimumab) available at District of Columbia pharmacies. Save up to 45% on your prescription — no insurance required.
Top Alternatives in District of Columbia
Hadlima (adalimumab biosimilar)
generic
FDA-approved biosimilar — interchangeable with Humira
Avg cash price: $1200/mo
Hyrimoz (adalimumab biosimilar)
generic
High-concentration biosimilar, citrate-free
Avg cash price: $1100/mo
Methotrexate
therapeutic
Non-biologic DMARD — much lower cost, discuss with rheumatologist
Avg cash price: $30/mo
District of Columbia Prescription Assistance Programs
DC Medicaid Rx (DC Health Care Alliance)
Prescription drug coverage for DC Medicaid beneficiaries and uninsured DC residents with incomes up to 200% FPL through the DC Health Care Alliance program.
Eligibility: Low-income DC residents including adults up to 215% FPL for Medicaid, and uninsured adults through the Alliance program.
DCPAP (DC Pharmaceutical Assistance Program)
Assists eligible low-income DC seniors with Medicare Part D co-payments and coverage gaps.
Eligibility: DC residents aged 65+ enrolled in Medicare Part D with income at or below 300% FPL. Contact the DC Office on Aging at 202-724-5622.
Frequently Asked Questions
Are Humira biosimilars as effective as the original?
FDA-approved biosimilars for Humira are deemed highly similar with no clinically meaningful differences in safety or efficacy.
How much do Humira biosimilars cost?
Biosimilars like Hadlima and Hyrimoz typically cost 30–80% less than brand Humira, though prices vary significantly by pharmacy and insurance status.
Can Script Unlock help with biologic costs?
Some Script Unlock pharmacies carry biosimilars and offer cash-pay pricing. It is worth posting your prescription to see available bids.